Why Are Moderna Executives Dumping Their Stock?
The U.S. Health and Human Services' Operation Warp Speed has pledged to deliver 300 million doses of a COVID-19 vaccine by 2021, if not sooner. However, developing a safe and effective vaccine normally takes years and begins with animal studies. The COVID-19 vaccines are all being rushed straight into human clinical tests, forgoing lengthy animal trials altogether.
Such fast-tracked vaccines pose unknown risks, which are further magnified since governments are granting COVID-19 vaccine makers immunity from liability for all vaccine injuries and deaths that occur after the vaccines are recommended (or mandated) by public health officials.
At the end of July 2020, AstraZeneca announced most countries it expects to supply with COVID-19 vaccine will grant the pharmaceutical company complete liability protection if people are harmed.
In the U.S., vaccine makers already have something of a "free pass" when it comes to vaccine injury liability and lawsuits through the National Childhood Vaccine Injury Act of 1986 and the Public Readiness and Emergency Preparedness (PREP) Act, passed in 2005.
The main concern is that the combination of COVID-19 vaccines being fast-tracked to market at "warp speed" with minimal testing, together with blanket liability protection against vaccine injuries could be a public health nightmare in the making.
Problems With Moderna’s Vaccine Are Becoming Apparent
Early warning signs that something might be amiss have already started emerging. As detailed in “Gates Tries to Justify Side Effects of Fast-Tracked Vaccine,” results from Moderna’s Phase 1 human trial revealed 100% of volunteers in the high-dose group suffered systemic side effects. Side effects included fatigue, chills, headache and myalgia (muscle pain); 21% suffered “one or more severe events.”
According to Bill Gates, those side effects are largely due to the high dosages Moderna had to use in order to achieve desired antibody levels. But, if high dosages are required to create a robust-enough immune response, and higher dosages also cause systemic side effects in nearly all people, just how safe will this vaccination campaign be?
Moderna Executives Have Raked in Millions on Dumped Stocks
As reported by NPR September 4, 2020, executives at Moderna have also cashed in stock options, raking in tens of millions of dollars of personal profit in the process. Considering the patent problems now emerging and the lingering safety and efficacy questions, this move has raised significant concerns among financial experts.
more https://articles.mercola.com/sites/articles/archive/2020/09/21/coronavirus-vaccine-patent.aspx
https://www.npr.org/2020/09/04/908305074/bad-optics-or-something-more-moderna-executives-stock-sales-raise-concerns